Other immune-related genes that were highly expressed post-therapy in non-responders include CD79A, CD164, C7, CCR1, and JAK3. CD164 (sialomucin) is involved in the regulation of cell proliferation and apoptosis, and the overexpression is detected in cancer patients [60]. Here, CD164 is linked to cancer.